News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FusionPharm Receives Commitments for Use of GroPods for Medical Cannabis Cultivation



8/24/2011 11:03:47 AM

DENVER, Aug. 24, 2011 /PRNewswire/ -- FusionPharm Inc. (PINKSHEETS: FSPM), an ancillary product and service provider for the medical cannabis industry, is pleased to announce that they have received commitments for their first 7 available GroPods cultivation containers in the City of Denver. The company received preliminary approval from the City of Denver for use of their GroPods in the licensed medical cannabis cultivation industry in July and expects to complete construction and install the first units by the end of the month.

"This is a very exciting time for the company as we launch GroPods into the marketplace," said company CEO Scott Dittman. "Pre-launch interest has exceeded our expectations and we are ramping up our production to meet the market demand."

About FusionPharm Inc.

FusionPharm Inc. (http://www.fusionpharminc.com) provides a focused variety of support products and ancillary services primarily to the medical cannabis industry. More specifically, FusionPharm provides specialty equipment such as GroPods, financing, consulting and other industry-specific services to the nascent medical cannabis industry.

The Company is NOT engaged in growing, harvesting, cultivation, possession or distribution of marijuana.

Notes About Forward-Looking Statements:

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made. For more information about GroPods or any of FusionPharm Inc.'s products or services, call them at 720-458-0686 or view them on the web at http://www.fusionpharminc.com.

SOURCE FusionPharm Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES